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Abstract: Alginate is a commonly used biomedical
hydrogel whose in vivo degradation behavior is only be-
ginning to be understood. The use of alginate in the cen-
tral nervous system is gaining popularity as an electrode
coating, cell encapsulation matrix, and for duraplasty.
However, it is necessary to understand how the hydrogel
will behave in vivo to aid in the development of alginate
for use as a neural interface material. The goal of the cur-
rent study was to compare the rheological behavior of
explanted alginate disks and the inflammatory response to
subcutaneously implanted alginate hydrogels over a 3-
month period. Specifically, the effects due to (1) in situ gel-
ling, (2) diffusion gelling, and (3) use of a poly-L-lysine
(PLL) coating were investigated. While all samples’ com-
plex moduli decreased 80% in the first day, in situ gelled
alginate was more stable for the first week of implantation.
The PLL coating offered some stability increases for diffu-
sion gelled alginate, but the stability in both conditions
remained significantly lower than that in in situ gelled al-
ginate. There were no differences in biocompatibility that
clearly suggested one gelation method over another. These
results indicate that in situ gelation is the preferred method
in neural interface applications where stability is the pri-
mary concern.  2007 Wiley Periodicals, Inc. J Biomed
Mater Res 83A: 1128–1137, 2007
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INTRODUCTION
Recently, there have been several reports using al-
ginate in advanced neural interface technologies.
These include microelectrode coatings, cell scaffolds,
neural stem cell encapsulation, and development of
an artificial dura mater.1–7 Alginate shows promise
and utility as a material in the development of
advanced neural interfaces. Its long-term biocompat-
ibility, mild reaction conditions that allow hydrogel
cross-linking while in direct contact with neural tis-
sues, and minimal risk of seizure activity in rats are
especially important considering the imminent and
prolonged contact of the hydrogel components with
neural tissues.1,8–14 Unfortunately, little is known
about the long-term stability of alginate, which may
be important to the lifetime of advanced neural pros-
thetic devices incorporating this material.
Alginate is a naturally occurring polysaccharide
copolymer that can be used to create hydrogels with
a broad range of material properties. Derived from
brown algae, alginate is composed of blocks of both
b-D-mannuronic acid (M) and a-L-guluronic acid (G)
linked together by 1,4-bonds.15,16 Alginate is water
soluble and can be ionically cross-linked by various
divalent ions.17 Currently Ca2þ is preferred to cross-
link alginate for biomedical applications because of
the mild reaction conditions compared to the cellular
toxicity of both Ba2þ and Sr2þ.10,17–19 In the process
of cross-linking, the calcium ions interact with the
carboxyl groups of the G blocks of two neighboring
alginate chains forming an ‘‘egg box’’ orientation.20
Because of the large variety of alginate sources and
G and M block ratios, the properties of the resulting
cross-linked gels can be highly variable. Alginate
with a higher G content typically results in stronger
gels; while alginate with a higher M content yields
more flexible gels.21
Two methods of gelation have been extensively
described and used to create alginate hydrogels: dif-
fusion gelling and in situ gelling (Fig. 1).10,17,19,22–30
CaCl2 is a commonly used calcium source that relies
on diffusion to cross-link alginate. Ca2þ can readily
dissociate from the Cl to cross-link the first carboxyl
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groups with which it comes into contact. This rapid
reaction creates a skin around the volume of liquid
alginate. Subsequently, the calcium ions diffuse
inward (i.e., diffusion gelling), increasing the skin’s
thickness as the alginate bolus is cross-linked.31,32
Although this results in rapid gel formation, the
resulting hydrogel structure is highly variable.12,32
Despite this, diffusion gelling remains an ideal
approach that is widely used for rapidly encapsulat-
ing cells in microspheres of alginate.23,33–37
CaCO3 and CaSO4 are commonly used Ca
2þ sour-
ces that rely on internal gelling through the release
of calcium ions in situ. In the case of CaCO3, poorly
soluble calcium ions in the form of CaCO3 are homo-
geneously mixed with alginate and then the Ca2þ is
solubilized by the addition of catalyst, such as D-glu-
cono-d-lactone (GDL). GDL slowly acidifies the algi-
nate:CaCO3 solution, driving the release of Ca
2þ.26,38
Calcium ions bind to the nearest available carboxyl
groups on the alginate molecules, cross-linking the
hydrogel in a spatially uniform manner. This
method can be time intensive due to the time
required for the hydrolysis of GDL and subsequent
calcium release; however, the resultant hydrogel has
a more uniform and reproducible structure.23,26,38
Diffusion gelled alginate has previously been
shown to destabilize both in vitro and in vivo.39–41
Prolonged exposure to sodium ions decreases both
compressive and shear stiffness of alginate, suggest-
ing that physiological conditions will soften the gel
over a time period of up to 7 days after gelation.40
Further, LeRoux et al. showed that high M alginate
hydrogels exhibited a significant decrease in com-
plex modulus but retained solid-like behavior after 7
days of exposure to 0.15M NaCl and 1.8 mM
CaCl2.
40 Kong et al., however, demonstrated the
superior retention of elastic modulus of high G algi-
nate over high M alginate implanted up to 35
days.39 This effect is due to calcium’s higher affinity
for G sites than M sites, resulting in a more dense
distribution of cross-links in a high G concentration
hydrogels. This dense distribution of cross-links
enhances the stability of high G alginate hydrogels
after prolonged exposure to the inert electrolytes
found in vivo, thereby decreasing the effect of ion
exchange at the cross-link site.39 While these previ-
ous studies support our current investigations of
high G alginate stability in vivo, there are currently
no studies that investigate stability differences based
on gelation method.
Poly-L-lysine (PLL) coatings are commonly used to
stabilize alginate capsules and provide a barrier to
immune system components such as IgG in cell
encapsulation applications.42,43 Unfortunately, there
is evidence that the PLL coating itself may be toxic
to encapsulated cells and cause an unfavorable for-
eign body response.44–47 Additionally, claims that
PLL coatings improve alginate mechanical stability
have been based on in vitro findings. PLL-coated al-
ginate capsules seeded with proliferative cells
remained intact for longer periods of time compared
to noncoated capsules in culture.37,48 Given the
potential toxicity of PLL on encapsulated cells, these
results may be confounded by a slight reduction in
Figure 1. Diffusion and in situ gelling of liquid alginate. (A) Diffusion gelling. Calcium ions diffuse through the liquid al-
ginate boundary, cross-linking alginate strands as the ions move through the volume of alginate. Cross-links are not uni-
formly distributed throughout the gel. (B) In situ gelling. CaCO3 is mixed with alginate to create a homogeneous mixture
(black circles). D-Glucono-d-lactone (GDL, grey circles) is added to acidify the solution and release calcium ions, making
them available for cross-linking. The resultant hydrogel has a uniform distribution of cross-links.
STABILITY AND BIOCOMPATIBILITY OF CALCIUM ALGINATE DISKS 1129
Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
cell proliferation, which could in turn result in more
stable capsules. While quantitative testing has
revealed that increased PLL membrane thickness cor-
responds with more mechanically stable nonseeded
capsules in vitro, quantitative in vivo mechanical test-
ing has not been reported in the literature.49 Given
that polycation coatings remain controversial after 25
years of research due to questionable biocompatibil-
ity, and that quantitative in vivo material testing data
is lacking, there is a clear need to explore the in vivo
biocompatibility and stability of PLL-coated alginate
in comparison to uncoated alginate.50
In the current study, we investigated alginate
disks cross-linked with CaCl2 or CaCO3 and meas-
ured each of the following parameters over time: (1)
weight changes, (2) complex modulus, (3) loss angle,
and (4) biological response to the subcutaneously
implanted disks. Additionally, we investigated the
effects of PLL coatings on CaCl2 cross-linked algi-
nate disks on these same four parameters. The goal
of this paper was to identify stability and biocompat-
ibility differences in diffusion gelled and in situ
gelled alginate samples and evaluate the necessity of
PLL coatings for enhanced stability. Specifically, we
wanted to identify any advantages (biocompatibility
or stability) of the specific gelation methods and
hydrogel coating to guide future development of
advanced neural interface technologies.
MATERIALS AND METHODS
Alginate hydrogel preparation
High G content sodium alginate (66% G acid) was
acquired from Novamatrix (Pronova UP LVG, Drammen,
Norway). Noncoated hydrogels were prepared as previ-
ously described, but with sterilized chemical components.7
Briefly, 1.95 wt % 43 mPa s alginate was cross-linked fol-
lowing one of the reaction schemes outlined in Figure 1.
The gelation method and volume of the resulting hydrogels
for each specific experiment is outlined in Table I. Rheology
hydrogels were created in a sterile 10 mL beaker: 2 mL algi-
nate was reacted with (1) 100 mM CaCO3 (Sigma, St. Louis,
MO) and 80 mM GDL (Sigma, St. Louis, MO) (final concen-
trations), or (2) 2 mL 200 mM CaCl2 (Sigma, St. Louis, MO)
(Table I). Histology hydrogels were created in a single well
of a sterile 24-well tissue culture plate: 500 lL of alginate
was reacted with (1) 100 mM CaCO3 and 80 mM GDL (final
concentrations), or (2) 500 lL 200 mM CaCl2 (Table I).
Hydrogels created via in situ gelling (CaCO3) were well
mixed before addition of GDL to ensure homogeneous dis-
tribution of cross-links throughout the gel. Hydrogels cre-
ated via diffusion gelling (CaCl2) were cross-linked by
slowly pipetting the CaCl2 solution onto the bolus of algi-
nate. All gels were allowed to fully cross-link under sterile
conditions for 12 h prior to implantation.
To test the effect of a PLL coating, CaCl2 hydrogels
made for rheology and histology were additionally coated
with PLL (CaCl2/PLL) as described by Strand et al. (Table
I).51 Briefly, alginate disks were rinsed in physiological sa-
line and incubated for 10 min in 0.1% PLL in saline. PLL–
HCl (15,000–30,000 MW) was obtained from Sigma (St.
Louis, MO). Disks were rinsed again in saline and incu-
bated for 10 min in 0.1% alginate in saline. Disks were
rinsed a final time in saline prior to implantation. To main-
tain similarity to PLL coated hydrogels, CaCl2 gels were
also rinsed in saline several times prior to implantation.
Surgery
Alginate hydrogel stability and biocompatibility were
tested in 300 g Sprague Dawley rats (Charles River Labora-
tories, Wilmington, MA). All procedures were approved by
the University of Michigan Committee on Use and Care of
Animals. Anesthesia was administered using an intraperito-
neal injection of an anesthetic cocktail (comprised of Keta-
mine, Xylazine, and Acepromazine, each at concentrations
of 100 mg/mL and a respective mixing ratio of 5:0.5:1)
administered at 0.15 mL/100 g body weight. Rats were
indicated for rheology or histology before surgical implan-
tation due to the size difference in the gels. All hydrogels
were implanted in separate subcutaneous pouches created
on the abdomen and the skin was securely closed with sur-
gical staples.
Forty-eight rats were used in the rheology study, each
receiving four hydrogels. The hydrogel conditions (CaCO3,
CaCl2, or CaCl2/PLL) were chosen at random for each ani-
mal, but no animal received more than two gels of the same
condition. At the time of hydrogel recovery, the rats were
deeply anesthetized with anesthetic cocktail (0.3 mL/100 g
body weight) and then euthanized with a cardiac injection
of 1 mL Fatal-Plus1 (Pentobarbital 390 mg/mL, Vortech
Pharmaceutical, Dearborn, MI). Five hydrogels per condi-
tion were recovered at each time point (1, 3, 5, 7, 14, 21, and
90 days) by removing the hydrogel from the subcutaneous
TABLE I
The Gelation Conditions for All Hydrogels to be Implanted Subcutaneously and Analyzed via Rheology or Histology
Experiment Alginate Volume (ml) Cross-linker Volume GDL (mg) PLL Coating n per Time Point
CaCO3 Histology 0.5 5 mg 7.1 No 6
Rheology 2 20 mg 28.4 No 5
CaCl2 Histology 0.5 0.5 mL; 200 mM 0 No 6
Rheology 2 2 mL; 200 mM 0 No 5
CaCl2/PLL Histology 0.5 0.5 mL; 200 mM 0 Yes 6
Rheology 2 2 mL; 200 mM 0 Yes 5
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pouch. All hydrogels were weighed and rheological meas-
urements taken immediately following explantation.
Twelve rats were utilized in the histology study. Each
rat was implanted with two gels per condition for all con-
ditions (CaCO3, CaCl2, and CaCl2/PLL), resulting in a total
of six implants per animal. At each predetermined time
point (7, 14, 21, and 90 days), the hydrogels were recov-
ered from three rats per time point to evaluate the biologi-
cal response to the implants. Rats were euthanized in the
same manner as described for the rheology study. The tis-
sue and alginate disk were explanted en bloc and treated
with Bouin’s Fixative for 24 h.
Disk weight change
To determine the swelling/shrinking behavior of the
hydrogels, all gels indicated for rheology were weighed
prior to implantation. Immediately upon explantation, all
gels were weighed again to determine an increase or
decrease in disk weight. The average weight difference
and standard error were calculated for each hydrogel con-
dition (CaCO3, CaCl2, and CaCl2/PLL) and time point (1,
3, 5, 7, 14, 21, and 90 days).
Rheology: complex modulus and loss angle
The viscoelastic behavior of the hydrogels was tested
with a parallel plate rheometer (AR 550, TA Instruments,
New Castle, DE) using a 25-mm plate at 378C. The alginate
samples were compressed to 10% and subjected to a 1%
strain across a frequency sweep of 1–100 rad/s at each
level. Sandpaper (150-grit) was placed on the plate surfa-
ces to minimize the occurrence of slip at the plate/sample
interface. The storage (G0) and loss moduli (G@) were calcu-
lated by the rheometer and recorded for further analysis.
The complex modulus (G*), which represents the fre-
quency-dependent stiffness of the hydrogel, and loss angle,
d, which provides a relative measure of viscous effects to
elastic effects in a material, were calculated as previously
described.7 Low values of d indicate minimal internal
damping, a result of energy dissipation and internal fric-
tion in deformation cycles due to internal entanglements
and cross-link density (d ¼ 08, elastic solid; d ¼ 908, New-
tonian viscous fluid).40 The response of alginate to shear is
a good indicator of the fatigue resistance and how it will
perform in vivo. Brain tissue typically exhibits a complex
modulus ranging from 1 to 24 kPa and alginate is expected
to remain in this range.52 For application in or on the
brain, the frequency range of 1–5 Hz was chosen, as this
represents the heart rate frequency range of humans and
rats and therefore the highest oscillation rate the gels
would be exposed to in vivo. Average G* and d and the re-
spective standard errors at 1 and 5 Hz were calculated.
Histology
Tissue samples were dehydrated in a graded series of
ethanol washes (10–70%), embedded in paraffin, and sec-
tioned with a microtome. Two 8-lm-thick sections per
implant were each stained with hematoxylin and eosin
(H&E) or Masson’s trichrome (MT) based on previous
reports.53,54 H&E-stained sections were used to detect the
presence of inflammatory response cells.
MT-stained sections were used to assess the degree of
cell infiltration surrounding the implant on a qualitative
scale (0–4), and to quantitatively evaluate the thickness of
the encapsulating collagen layer as described.41,53,55 The
scoring levels indicated increasing levels of infiltration: 0 –
no cells present on the surface of the alginate; 1 – less than
50% of the surface area of alginate covered by cellular
attachment indicating minor infiltration; 2 – greater than
50% of the surface area of alginate covered by cellular
attachment indicating moderate infiltration; 3 – 100% of the
surface area of alginate covered by cellular attachment indi-
cated severe infiltration. Due to the amount of variation
seen in both of these measurements, infiltration scores were
taken from 10 separate hydrogel fragments in different
regions of the same tissue section. Similarly, collagen thick-
ness was measured around 10 separate hydrogel fragments
by taking eight equally spaced measurements around each
fragment. The repeated measures for each parameter (cell
infiltration and encapsulation thickness) for a given tissue
section were averaged, resulting in one infiltration score
and one encapsulation thickness per section. For each pa-
rameter the results for a condition then were combined to
calculate the average and standard error for each condition
(7, 14, 21, and 90 days for CaCO3, CaCl2, and CaCl2/PLL).
Statistics
All results were analyzed for normality and subse-
quently analyzed by the appropriate ANOVA (parametric
or nonparametric). When indicated, the appropriate post
hoc test was utilized to determine significant differences in
the data. The statistical test used in each situation is
reported with the results for each section of the study.
RESULTS
Disk weight change
Because of the nature of gelation and coating of
the hydrogels, the gels had significantly different
initial weights (Dunn’s comparison test). CaCO3
reacted alginate was significantly heavier than CaCl2
or CaCl2/PLL reacted alginate (p < 0.001, Fig. 2A).
CaCl2/PLL hydrogels were also significantly heavier
than CaCl2 reacted alginate (p < 0.001, Fig. 2A) due
to the PLL coating of the hydrogel.
Hydrogel weights varied with duration of implant
(Fig. 2B). CaCO3 reacted hydrogels trended towards
a continual decrease in weight over the entire time
course (p < 0.001, Kruskal–Wallis ANOVA). CaCl2
and CaCl2/PLL gels both decreased in weight on day
1, but subsequently demonstrated a significant weight
gain up to day 7 before significantly decreasing
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in weight for the remainder of the implant duration (p
< 0.005, Kruskal–Wallis ANOVA). Both CaCO3 and
CaCl2/PLL hydrogels decreased approximately 30 wt
% by day 90, but CaCl2 only decreased 17%.
Rheology: complex modulus and loss angle
G* varied with both experimental condition and
time. No significant difference in G* existed between
experimental conditions initially (p ¼ 0.099, ANOVA).
A large decrease (> 80%) in G* was determined for all
experimental conditions for 1 day post implant (p <
0.001, Fig. 3A). By day 3, G* was significantly greater
for CaCO3 reacted alginate than CaCl2 or CaCl2/PLL.
This phenomena continued until day 7 (p < 0.01, Fig.
3A), after which no significant differences in G*
existed between the hydrogels. CaCl2/PLL was signif-
icantly greater than CaCl2 on day 7 (p < 0.01). When
the G* data for the hydrogels were normalized to their
initial (day 0) measurements, G* for CaCO3 was signif-
icantly greater than CaCl2 or CaCl2/PLL for days 1–7
for both 1 and 5 Hz (p < 0.01, Fig. 3B and C) and
CaCl2/PLL was significantly greater than CaCl2 on
day 7 (p < 0.01). At day 14 and above, there was no
significant difference in G* between the three different
conditions, but G* increased significantly for all exper-
imental conditions (p < 0.05).
d varied with experimental condition and time.
CaCO3 had a significantly lower d than CaCl2 or
CaCl2/PLL on days 0 and 1 (p < 0.001, ANOVA, Fig.
3D). All three conditions varied significantly with
time (p < 0.001). d significantly decreased for all con-
ditions up to 3 days post implant (p < 0.01) and then
slowly increased up to day 90, significantly exceeding
initial d measurements by 2.5 times (p < 0.001). When
d was normalized to the initial measurements for
each condition, no difference was detected until day
3 (Fig. 3E and F). On day 3, CaCO3 was significantly
greater than CaCl2 (p < 0.01), and on day 5, CaCO3
was significantly greater than CaCl2 and CaCl2/PLL
(p < 0.01) at both 1 and 5 Hz. There was no signifi-
cant difference at any other time point.
Histology
In general, CaCO3 and PLL-coated implants were
more intact than uncoated CaCl2 implants at 7 days.
After day 14, all disks displayed increasing levels of
hydrogel fragmentation with collagen around each
fragment, increasing the separation of the fragment
from the main disk. Macrophages were seen in the
tissue around all disks at all of the time points (Fig.
4). After 21 and 90 days, fibrosis and granulation tis-
sue were present in the surrounding connective tis-
sue and were indicative of normal wound healing
(Fig. 4).
The encapsulation layer thickness varied with time
(Fig. 5). Collagen encapsulation was low initially,
then increased significantly at day 14 for CaCl2 and
CaCl2/PLL implants and 21 days for CaCO3 hydro-
gels (p < 0.05, ANOVA). Encapsulation thickness
was in the range of 15–35 lm for all conditions at
14, 21, and 90 days post-implantation. CaCO3 gels
had significantly thicker encapsulation than other
conditions on day 21 (p < 0.05) but no other signifi-
cant differences were detected.
Figure 2. Differences in hydrogel weight. (A) On day 0, the alginate’s weights were significantly different for each condi-
tion. CaCO3 reacted gels were the heaviest initially (p < 0.001). CaCl2/PLL hydrogel were significantly heavier than CaCl2
reacted gels on day 0 (p < 0.001). (B) Hydrogel weight changes with time. All of the hydrogels decreased in weight on
day 1; however, the weights of the CaCl2 and CaCl2/PLL hydrogels then increased until day 7. After day 7, these gels
begin to decrease in weight for the remainder of the time course. CaCO3 hydrogels decreased in weight over the entire
time course. n ¼ 5.
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Cell infiltration of the alginate disks varied with
time (Fig. 6). Cell infiltration was initially high (scores
ranged from 0.9 to 1.5 on day 7), and then significantly
decreased for all conditions (p < 0.05, ANOVA). No
significant differences in cell infiltration were detected
between the conditions at any time point.
Figure 3. G* and d changes over time at 10% compression. (A)–(C): G* changes over time at 1 and 5 Hz. (D)–(F): d changes
over time at 1 and 5 Hz. A. Raw data average G* for each time point at 1 Hz. Initially, G* for CaCO3 was smaller than G*
for either CaCl2 or CaCl2/PLL, but increased by day 7 to become significantly greater than both conditions (p < 0.01). After
day 14, G* increased for all conditions. B. Normalized G* averages for each condition over time at 1 Hz. G* for CaCO3 was
greater than CaCl2 and CaCl2/PLL for all time points except day 90. C. Normalized G* averages for each condition over
time at 5 Hz. G* for CaCO3 remained greater than CaCl2 and CaCl2/PLL for all time points except day 90. D. Raw data av-
erage d for each time point at 1 Hz. d for CaCO3 was lower than CaCl2 and CaCl2/PLL until day 5. After day 14, d increased
for all conditions (p < 0.001). E. Normalized d averages for each condition over time at 1 Hz. d for all conditions decreased
until day 3 and then increased to day 90. F. Normalized d averages for each condition over time at 5 Hz. d changes were
smaller at 5 Hz than 1 Hz and no significant increase was detected until day 90 for all conditions. n ¼ 5.
Figure 4. Inflammatory response to alginate over time. Micrographs are at 4003 magnification of HE stained sections.
The scale bar in C represents 50 lm in all micrographs. A. CaCl2/PLL samples 7 days post implantation. Fragmentation of
the alginate (A, not all labeled) has already begun and many macrophages and lymphocytes were present in the tissue
and around the alginate. B. CaCl2 reacted alginate, 14 days post implantation. Fibroblasts had begun secreting collagen
around the alginate fragments (A, not all labeled). Macrophages were still present in the tissue (indicated by arrows). C.
CaCO3 reacted alginate, 90 days post implantation. A thick encapsulation layer was detectable around the alginate (A)
filled with fibroblasts and new capillaries which comprise granulation tissue (**). [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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DISCUSSION
To gain insight into the destabilization of alginate
for the development of advanced neural interface
technologies, we investigated the stability and bio-
logical response to alginate in the rat subcutaneous
implantation model. The responses demonstrated in
this experimental paradigm were expected to be
representative of alginate degradation in neural
interface applications, albeit a more rigorous test
environment. The effects due to in situ gelling versus
diffusion gelling and use of a PLL coating were
investigated. While all samples’ complex moduli
decreased 80% in the first day, the in situ gelled algi-
nate was more stable for the first week of implant.
More significantly, the in situ gelled alginate was the
only condition that remained within the biologically
relevant G* range over the entire 3-month period.
This indicates that there is an increased potential of
mechanical failure for diffusion gelled alginate dur-
ing the first week of implant, even in the presence of
a PLL coating. However, there were no differences
in the histology that would clearly suggest the use
of one gelation method over another. Additionally,
there appears to be no significant differences
between the mechanical stability of the different
hydrogels after the first week. Based on these results,
the use of in situ gelled alginate is more desirable
than diffusion gelled alginate in neural interface
applications that require high stability during the
first week of implantation.
In situ gelled alginate disks exhibited significantly
different weight changes compared to diffusion
gelled alginate disks. Although all of the hydrogels
exhibited a decrease in weight on the first day, indi-
cating an exudation of liquid, CaCO3 continued to
decrease in weight over all time points, indicative of
hydrogel degradation over time.56 Conversely, CaCl2
and CaCl2/PLL hydrogels increased in weight for
the first week indicating swelling but then decreased
in weight, exhibiting similar hydrogel degradation
behavior as CaCO3.
56 A larger weight change for
Figure 5. Collagen encapsulation thickness around algi-
nate disks over time. Encapsulation thickness increased
over time for all conditions (p < 0.05). No difference
existed between conditions except day 21; CaCO3 reacted
alginate had a significantly thicker encapsulation layer
than CaCl2/PLL or CaCl2 (p < 0.05, *; n ¼ 6).
Figure 6. Cellular infiltration of alginate disks over time. (A) Initially, cell infiltration approached moderate levels for all
gel conditions (2  x  1), but decreased by day 14 and stabilized at minor infiltration levels (x  1). This decrease from
day 7 was significant for all conditions (p < 0.05) and there was no significant difference between conditions at any time
point, n ¼ 6. (B) A representative micrograph (CaCl2, 7 days post implant) illustrating the varied nature of the infiltration
level in a single condition (A indicates alginate fragments). The scale bar represents 200 lm. [Color figure can be viewed
in the online issue, which is available at www.interscience.wiley.com.]
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CaCl2/PLL hydrogels than CaCl2 hydrogels after 3
months was also detected but is likely due to the
loss of the PLL coating, which accounted for initial
weight differences between the two experimental
conditions. The initial exudation of liquid explanation
is supported by the measured decrease in d for all of
the conditions on day 1. An exudation of liquid with-
out hydrogel degradation would cause an increase in
internal entanglements detected as a decrease in d.40
This may also be responsible for the significant
decrease in G* seen on day 1. The movement of water
out of the hydrogel could have changed the underly-
ing structure of the hydrogel enough to cause the
observed decrease in G*. Based on these observations,
the authors hypothesize that the exudation of liquid
from the alginate matrix initially causes the hydrogel
to lose stability due to a loss of hydrogen bonding
within the matrix and a loss of surface tension on the
surfaces of the hydrogel.
Alginate degradation over time was not evident in
all of the experimental outcomes. The weight change
stabilized for all of the experimental conditions
between days 21 and 90. Over these same time
points, G* increased, indicating increasing hydrogel
stiffness with time. However, this weight stabiliza-
tion and increase in G* was accompanied by a signif-
icant increase in d indicating degradation of the
hydrogel structure. The lack of agreement between
the data can be explained by the replacement of the
degrading alginate with fibroblasts and collagen.
The formation of granulation tissue amid the
remaining degrading alginate fragments between
these two time points contributed to the observed
weight stabilization, increased G*, and decreased d
for all hydrogel conditions.
Alginate disk fragmentation was an unexpected
phenomenon demonstrated by all of the experimen-
tal conditions. The fractionation of the implants
increased with sequential time points, making me-
chanical testing increasingly more difficult. All of the
alginate pieces collected for a given disk sample
were used together for these studies. The authors
hypothesize that the fragmentation was due to the
combination of destabilization of calcium cross-links
by phosphates in the extracellular fluid and phago-
cytosis of alginate fibers by macrophages.
Due to the pulsation of the brain with heart rate and
respiratory rate, the alginate will be subject to oscilla-
tory strain in vivo. The response of alginate to shear is
a good indicator of the fatigue resistance and how it
will perform in vivo. Brain tissue typically exhibits a
complex modulus ranging from 1 to 24 kPa.53 It is nec-
essary for alginate to remain in this range to avoid fa-
tigue when used in the central nervous system.
CaCO3 reacted alginate disks all remained in this
range for all time points, indicating sufficient long-
term stability. CaCl2 hydrogels fell below this range
on days 3, 5, 7 and CaCl2/PLL hydrogels on days 3
and 5 indicating material fatigue. This is can be attrib-
uted to the swelling demonstrated by the hydrogels
over this timeframe, which disrupted the hydrogels’
underlying chemical interactions and structure.39,57
Previously, Strand et al. determined that PLL coated
alginate caused a fibrotic reaction more quickly than
alginate alone.58 Although a similar effect was not
detected in the current study, it is possible that low
level fibrosis was responsible for the increase in G*
over uncoated CaCl2 gels on day 7. Based on these
results, diffusion-gelled alginate hydrogels have
potential to mechanically fail during the first week of
implant when used as a neural interface material.
Cellular infiltration for the alginate disks was due
to the large pore size and phagocytosis of the surface
alginate fragments. Although alginate is inherently
nonsticky and cells are not likely to adhere to the
alginate, they are able to treat it as a foreign body.
The pore size of gelled, high guluronic acid content
alginate is relatively large, 200–400 nm.59 This is suf-
ficient to allow phosphate molecules to diffuse into
the matrix, thereby destabilizing the ionic interac-
tions that hold the hydrogel together. Additionally,
the individual strands of alginate have been meas-
ured at 13–26 nm,59 small enough for macrophages
to begin sequestering portions of the destabilized
strands. This combination of destabilization and
phagocytosis is responsible for the early cellular
infiltration detected histologically.
The results indicate that in situ gelled alginate is
more stable in vivo than diffusion gelled alginate
during the first week of implantation. Based on ini-
tial hydrogel weights alone, diffusion gelled hydro-
gels would have been hypothesized to have a higher
cross-link density and improved stability. The signif-
icantly lower weight of CaCl2 reacted hydrogels
compared to CaCO3 reacted hydrogels potentially
indicated a lower level of water retention in the
hydrogel matrix. This was hypothesized to contrib-
ute to improved long-term stability of the hydrogels
but this is not what was found in the current study.
CaCO3 reacted alginate hydrogels had a significantly
higher G* and a significantly smaller decrease in G*
over the first 7 days (p < 0.01). CaCO3 reacted gels
additionally exhibited significantly lower d measure-
ments initially, indicating a denser distribution of
cross-links and entanglements which possibly con-
tributed to the improved stability in vivo. Previously,
Kong et al. indicated that high G alginate was more
stable than high M alginate due to the cross-link
density of the high G alginate.39 The high cross-link
density allowed the hydrogel to maintain a small
pore size and resist tissue growth and replacement
of the alginate scaffold used in that study.39 This ex-
planation of cross-link density contributing to stabil-
ity is applicable to the enhanced stability seen with
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CaCO3 gels over CaCl2 gels in the current study.
Additionally, in situ gelled alginate did not swell
like diffusion-gelled alginate, thereby minimizing the
influx of chemical species that disrupt the ionic
interaction of Ca2þ with the alginate carboxylic acid
residues.39 These mechanisms worked together,
maintaining the G* of in situ gelled alginate hydro-
gels within the biologically relevant range for
advanced neural interface technologies (1–24 kPa).
The authors gratefully thank Drs. Timothy Becker and
Paul Makidon, and Kaylan Brakora for insightful discus-
sions and Neural Intervention Technologies for the use of
their rheometer.
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